President Donald Trump announced $3 billion in new defense deals and joint ventures with NATO allies this week. The White House said the agreements will expand missile and drone …
The U.S. Food and Drug Administration (FDA) has approved a new drug, Kisunla (donanemab), aimed at treating Alzheimer’s disease. This approval is a significant development for patients in the early …